drugset / Trial / NCT05491343

Observation vs Progesterone Treatment for Management of Uterine Arteriovenous Malformation

NCT05491343

Phase 4 Unknown 28 enrolled HaEmek Medical Center, Israel
RandomizedParallel-groupOpen-labelTreatment

Summary

A randomized trial which compares conservative management to progesterone based treatment for arteriovenous malformation

Timeline

Start
2022-08
Primary completion
2022-12
Completion
2024-01

Drugs

EvaluationDrugModalityDoseRoute
Subject medroxyprogesterone acetate Other / unclassified